Cyanosis surgery: Difference between revisions
Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
== Recommendation for surgery in [[cyanotic heart disease]] == | == Recommendation for surgery in [[cyanotic heart disease]] == | ||
'''<span style="font-size:85%">'''Abbreviations:''' | |||
'''TGA:''' [[Transposition of great arteries]]; | '''TGA:''' [[Transposition of great arteries]]; | ||
'''PDA:''' Patent ductus arteriosus ; | '''PDA:''' Patent ductus arteriosus ; |
Revision as of 15:17, 27 October 2020
Cyanosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Cyanosis surgery On the Web |
American Roentgen Ray Society Images of Cyanosis surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Recommendation for surgery in cyanotic heart disease
Abbreviations:
TGA: Transposition of great arteries;
PDA: Patent ductus arteriosus ;
ASD: Atrial septal defect;
VSD: Ventricular septal defect;
TAPVR: Total anomalous pulmonary venous return;
TOF: Tetralogy of fallot;
CCTGA: Congenitally corrected transposition of the great arteries;
Recommendation for surgery in cyanotic congenital heart disease |
Indications for repair of a scimitar vein in Anomalous pulmonary venous connection (TAPVC) (Class I, Level of Evidence B ): |
❑ Decreased functional capacity |
Indications for surgery in Anomalous Pulmonary Venous Connections (TAPVC)(Class 2a, Level of Evidence B) : |
❑ Asymptomatic adults with right ventricle volume overload |
Indications for surgery repair or reoperation in Ebstein anomaly : (Class I, Level of Evidence B) |
❑ Significant tricuspid regurgitation in the presence of the following: |
Indications for surgery repair or reoperation in Ebstein anomaly:(Class 2a, Level of Evidence B) |
❑ Significant tricuspid regurgitation in the presence of the following: |
Indication for Glenn anastomousis at the time of repair in Ebstein anomaly : (Class 2b, Level of Evidence B) |
❑ Severe right ventricle dilation |
Indication for pulmonary valve replacement ( surgical or percutaneous in Tetralogy of fallot (Class I, Level of Evidence B): |
❑ Symptomatic Moderate to severe pulmonary regurgitation after repaired TOF in which symptoms can not be explained otherwise. |
Indication for Pulmonary valve replacement ( surgical or percutaneous in Tetralogy of fallot : (Class 2a, Level of Evidence B) |
❑ Asymptomatic moderate to severe pulmonary regurgitation after repaired TOF |
Indication for Tricuspid valve replacement in CCTGA : (Class I, Level of Evidence B) |
❑ Symptomatic severe tricuspid regurgitaion accompanied by preserved or mildly systolic dysfunction of systemic ventricle |
Indication for Tricuspid valve replacement in CCTGA : (Class 2a, Level of Evidence C) |
❑ Asymptomatic severe tricuspid regurgitation accompanied by mildly dilated systemic ventricle |
Indication for conduit intervention/replacement in CCTGA : (Class 2b, Level of Evidence B) |
❑ Symptomatic subpulmonary left ventricle to pulmonary artery conduit dysfunction |